Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Express Scripts
Boehringer Ingelheim
Fish and Richardson

Generated: October 23, 2017

DrugPatentWatch Database Preview

Claims for Patent: RE38968

« Back to Dashboard

Claims for Patent: RE38968

Title:Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
Abstract:The current invention provides a method useful for inhibiting the loss of bone using 6-hydroxy-2-(4-hydroxyphenyl)-benzo(B)-thien-3-yl-4[2-piperidin-1-ethoxyp- henol]methanone hydrochloride.
Inventor(s): Black; Larry J. (Indianapolis, IN), Cullinan; George J. (Trafalgar, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:10/375,339
Patent Claims: 1. A method of inhibiting .Iadd.post-menopausal .Iaddend.bone loss .Iadd.in a post-menopausal woman in need of treatment to prevent or treat post-menopausal osteoporosis .Iaddend.comprising administering to .[.a human.]. .Iadd.said woman .Iaddend.in need .[.thereof.]. .Iadd.of said treatment .Iaddend.an effective amount of 6-hydroxy-2-(4-hydroxyphenyl)-benzo[B]thien-3-yl-4-[2-(piperidin-1-yl)eth- oxyphenyl]methanone hydrochloride.

.[.2. The method of claim 1 wherein said human is female..].

3. The method of claim .[.2.]. .Iadd.1 .Iaddend.wherein said .[.human.]. .Iadd.woman .Iaddend.has .Iadd.post-menopausal .Iaddend.osteoporosis.

.Iadd.4. A method of inhibiting post-menopausal bone loss in a post-menopausal woman in need of treatment to prevent post-menopausal osteoporosis comprising administering to said woman in need of said treatment an effective amount of 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl)eth- oxyphenyl]methanone hydrochloride..Iaddend.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus